GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ceapro Inc (TSXV:CZO) » Definitions » Cash Flow for Lease Financing

Ceapro (TSXV:CZO) Cash Flow for Lease Financing : C$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Ceapro Cash Flow for Lease Financing?

Ceapro's Cash Flow for Lease Financing for the three months ended in Dec. 2023 was C$0.00 Mil. Ceapro's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Sep. 2023 ), Ceapro's Cash Flow for Lease Financing remained the same in Dec. 2023 (C$0.00 Mil).

Ceapro Cash Flow for Lease Financing Historical Data

The historical data trend for Ceapro's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ceapro Cash Flow for Lease Financing Chart

Ceapro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ceapro Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ceapro Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ceapro Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Ceapro's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Ceapro (TSXV:CZO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ceapro Inc (TSXV:CZO) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XCNQ:PHRM XCNQ:TELI XCNQ:MDMA TSXV:CYTO TSXV:SBM TSXV:KNE TSX:RVX TSX:ATE TSX:APS XCNQ:DOSE OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
CRPOF:USA
Address
7824-51 Avenue NW, Edmonton, AB, CAN, T6E 6W2
Website
https://www.ceapro.com
Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Active ingredients produced include oat beta glucan and avenanthramides. The group derives revenue from the U.S., Germany, China, Canada and other countries, of which prime revenue is generated from the U.S.

Ceapro (TSXV:CZO) Headlines

No Headlines